Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study

Assessment of efficacy and safety of DOACs in treatment of pulmonary embolisms in obese patients provides reassurance that treatment with DOACs carries similar rates of recurrent VTE and bleeding complications to warfarin https://bit.ly/2VdrSXX

Detalles Bibliográficos
Autores principales: Samaranayake, Chinthaka B., Keir, Gregory, Slader, Simon A.A., Tseng, T., Tran, Khoa, Anderson, James, McCann, Andrew, McCabe, Colm, Upham, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405875/
https://www.ncbi.nlm.nih.gov/pubmed/34476251
http://dx.doi.org/10.1183/23120541.00379-2021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405875/
https://www.ncbi.nlm.nih.gov/pubmed/34476251
http://dx.doi.org/10.1183/23120541.00379-2021

Ejemplares similares